The Self-Annointed Supplement Queen, Liz Gaspari and her one fan (herself)

Posted by on Aug 28, 2014 in Anthony Roberts | 0 comments

After the massive fail of trying to start her own charity (lulz at The Liz Gaspari Foundation_, then the fail of trying to work with/for G.E.A.R. Nutra (who couldn’t release a single product with her at the company), then announcing her partnership with FA Nutrition (what happened there, again…?), Liz Gaspari, the ersatz Supplement Queen, has launched her own…something. I have no idea what this is supposed to be, except a joke. For a woman who tells everyone that she’s the most powerful woman in the industry, her ego must be taking a pounding with the amount of companies not knocking down her door to work with her. So she’s started another …I don’t even know what to call this. What I do know is that this page, like Ms. Gaspari herself, only has one fan…and it’s the woman in her mirror.

SQ

(Or maybe it’s this kid…? Sweet duckface, bro.)

Liz

Read More

Selective Androgen Receptor Modulators (SARMs)

Posted by on Aug 26, 2014 in Featured, John Romano | 0 comments

My usefulness to the media seems to ebb and flow. I go months without so much as a friend request on Face Book then all of a sudden I have producers from three or four acronym news agencies sending me e-mails looking for a quote, or a lead, or whatever (I’m going to refer to the various news agencies that talk to me as “acronym” rather than spell out the network initials. I tend to think that the less I hear from them the further off the radar screens we’re falling and maybe if enough time goes by no one will really care again if healthy adult male athletes use steroids.

And, every time I get the feeling that little blip is going to disappear some fucking moron does something true to character. Then all of a sudden I get three e-mails, with acronyms in their return addys, asking me about that douche bag virgin-murder in Santa Barbara and if it’s true that “creatine” is a code word for “steroids” in the online communities.

These kinds of occurrences, while disappointing, are still none the less indicative of just how much the steroid issue is languid in stagnation. Nothing really changes, does it? “Steroids are bad so lets prove it” is the mantra of any news agency worth its salt. The seedier the news organization the more relentless and exaggerated the plot. Its getting to the point where I think I’m just going to change my e-mail address because this is getting very boring.

My faith was somewhat stimulated by the end of a conversation I had recently with a producer for a sports channel. He asked me the most basic of questions, really. Nothing sensationalistic and actually rather bland. He asked me what I thought would be a promising new compound/therapy/drug/whatever that might currently be in development that will take the place of traditional PEDs such as steroids.

As luck would have it, just as I was waiting out the question and getting ready to launch into my next-generation peptides or the Chinese gene doping schpeal from which I use to give them talking points, an email came through. Of course I opened it – you think I don’t multi task? – it was from a guy asking me if tamoxifen will reverse his gyno. Then, rather than go into the peptides or the Chinese gene doping schpeal – because I got derailed thinking about what a great tool tamoxifen is because it can selectively modulate (adjust) estrogen receptor activity – it was then that I had that “ah-ha” moment.

Photo provided by www.sarmssearch.com

Photo provided by www.sarmssearch.com

The most efficient treatments are always those that don’t “insult” surrounding tissues, or at least not to any great extent. The more specific, or selective, the treatment, the greater the chance of the desired effect. Many traditional cancer treatments, even more modern chemo therapies that “target” specific cancer cells, demolish the immune system in the process. More often than not the patient dies from the treatment and not the tumor. It’s like the weed killer killing the weeds along with the rest of the lawn.

In some time, the foregoing will be considered ancient medicine, such as the holes found poked in 1,000 year-old Peruvian skulls – the perimeters of the holes in the skulls show advance stages of healing, indicating that 1,000 years ago they were drilling holes in people’s heads in an attempt to “cure” something. One-thousand years from now, the remnants of chemo therapy will look just as barbaric in light of specialized technologies that can isolate and eliminate a brain tumor without even so much as taking off your hat. One-thousand years ahead of them, no one will even get brain tumors anymore due to something like a nano-bot vaccine injected into the amniotic fluid during the end of the first trimester that weeds through the genome of the fetus and programs out the possibility of developing specific types of cancer cells – or any other known viruses, infections and diseases – throughout its entire life, which could conceivably be very long. Selectivity at its finest.

“Selectivity” is the real difference between modern and ancient medicine. The more modern medicine gets, the more we will see selectivity be enhanced until medicine is a matter of identifying a problem then dispatching a specialized therapy designed to selectively hone in on just the specific cells that need modulating, and not bother anything else. Scientifically, we are at that level now. The capability does exist.

A drug that can either block or stimulate the same nuclear hormone receptor under different conditions is called a selective receptor modulator. If it can block or stimulate a receptor in a tissue selective manner, it may be able to mimic the beneficial effects in one tissue and, at the same time, minimize the unwanted effects of the natural or synthetic steroidal hormones in other tissues.

Given the state of affairs in the scientific community today, it is totally possible to, if not step above then certainly step along side, the typical courses of steroids and androgens. Technology exists today to, to some extent, introduce a means to selectively target and modulate androgen receptor cells to phase out the undesirable side effects typically associated with exogenous hormones and enhance the desirable effects.

Selective Androgen Receptor Modulators (SARMs)

 

SARM’s could offer the athlete the benefits of traditional androgens such as testosterone – increased muscle mass, increased strength, fat loss, etc. – while offering a much lower tendency to produce the unwanted side effects that are common with androgen use.

If you are able to stimulate a receptor in a tissue selective manner, e.g., muscle, it is possible to mimic the beneficial effects of androgen activation in muscles, and at the same time, minimize the unwanted effects of the natural or synthetic steroidal hormones in other tissues.

It is this specificity that makes these receptor modulators able to selectively cause muscle growth, while reducing or eliminating unwanted secondary side effects.

SARM’s offer the potential for harnessing the benefits of anabolic supplementation while at the same time minimizing the undesirable side effects. They also have the potential advantages of oral dosing, which is very limited when it comes to androgens.

Although still at an early stage of development, the potential for SARM’s is very high, because SARM’s offer high oral bioavailability without insult to the liver as with oral androgens and even some prohormones. SARM’s are anabolic even at low doses with high potential for increased strength, muscle mass, lowering body fat, endurance and recovery.

While the jury is still out on SARM’s as far as full blown admission into the bodybuilder’s arsenal of strength and mass gaining tools, they are still legal and do offer promise based on quite a bit of published research. I suggest investigating these compounds and giving them a try. There is certainly enough science to support their use today.

3

 

Read More

High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study

Posted by on Aug 23, 2014 in Studies | 0 comments

Study titled “High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study” deals with Crossfit and enjoyment. Click to read the full study: High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study

High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study

 

Abstract
Background:
Understanding exercise participation for overweight and obese adults is critical for preventing
comorbid conditions. Group-based high-intensity functional training (HIFT) provides time-efficient aerobic and
resistance exercise at self-selected intensity levels which can increase adherence; behavioral responses to HIFT are
unknown. This study examined effects of HIFT as compared to moderate-intensity aerobic and resistance training
(ART) on exercise initiation, enjoyment, adherence, and intentions.
Methods:
A stratified, randomized two-group pre-test posttest intervention was conducted for eight weeks in 2012
with analysis in 2013. Participants (n = 23) were stratified by median age (< or≥28) and body mass index (BMI; < or≥ 30.5). Participants were physically inactive with an average BMI of 31.1 ± 3.5 kg/m2, body fat percentage of 42.0 ± 7.4%, weight of 89.5 ± 14.2 kg, and ages 26.8 ± 5.9 years. Most participants were white, college educated,
female, and married/engaged. Both groups completed 3 training sessions per week. The ART group completed
50 minutes of moderate aerobic exercise each session and full-body resistance training on two sessions per week.
The HIFT group completed 60-minute sessions of CrossFit™ with actual workouts ranging from 5–30 minutes.
Participants completed baseline and posttest questionnaires indicating reasons for exercise initiation (baseline),
exercise enjoyment, and exercise intentions (posttest). Adherence was defined as completing 90% of exercise
sessions. Daily workout times were recorded.
Results:
Participants provided mostly intrinsic reasons for exercise initiation. Eighteen participants adhered (ART = 9,
81.8%; HIFT = 9, 75%). HIFT dropouts (p = .012) and ART participants (p = .009) reported lower baseline exercise
enjoyment than HIFT participants, although ART participants improved enjoyment at posttest (p = .005). More HIFT
participants planned to continue the same exercise than ART participants (p = .002). No significant changes in BMI
or body composition were found. Workouts were shorter for HIFT than ART (p < .001).
Conclusions:
HIFT participants spent significantly less time exercising per week, yet were able to maintain exercise
enjoyment and were more likely to intend to continue. High-intensity exercise options should be included in public
health interventions.


Keywords:
Exercise, High-intensity, Functional movements, Moderate-intensity, Overweight, Obese, CrossFit,Enjoyment, Adherence, Intentions
Read More

Injunction filed against RipoffReport.com by SAC County Prosecutor in IOWA

Posted by on Aug 9, 2014 in Anthony Roberts, Legal Documents, Uncategorized | 0 comments

A civil injunction has been filed against RipoffReport by the SAC County Prosecutor. This comes after he filed and executed a search warrant that named many former and current Progenex employees/owners. I can only imagine indictments are looming for many of them, and it seems doubtful that we will get out of August without one or more being arrested, and unlikley to see the end of Summer withoug seeing criminal charges against most, if not all of them.

At that point, I expect some major media outlet(s) to pick it up, and we’ll likely see some of the Crossfit bashing websites and news sources tying it directly to HQ, as they were aware for the entire time that they had criminals funding the CFG, and in fact, using the proceeds from selling their product(s) to Crossfitters to fund ongoing criminal enterprises. Because such an extensive paper trail exists, outlining HQ’s complete awareness of who was behing Progenex since 2010,  I do not anticipate HQ denying that they were aware, more likely we’ll see no-comments, or something about free market Ayn Rand, libertarianism, etc, etc…

 

Read More

MusclePharm NOT cleared of Amino Spiking

Posted by on Aug 8, 2014 in Anthony Roberts | 0 comments

I can’t even be bothered to comment on this too deeply, but Mark Lobliner and Stack3d have come out and publicly stated that MusclePharm isn’t spiking their products.

http://www.stack3d.com/2014/08/mp-iron-whey-spike-free.html

It’s understandable, because who would provide tests that didn’t actually prove what they were trying to prove, right? The claims that Iron Whey is clean were based on a set of tests (conveniently provided to them by MusclePharm) that didn’t include one of the aminos from last week’s press release (Taurine) nor did it include Creatine: (yes, you have to plow through all 14 pages to figure out that stuff was missing):

Is MusclePharm spiking their products? I don’t know. But these tests make me think it’s even more likely now, since they omitted two of the most likely culprits for spiking, one of which was specifically mentioned in last week’s press release. MusclePharm, based on these tests, are not “cleared” of anything. Not even close. Any clean verdict rendered by these tests is 100% unsupported. The fact that MusclePharm is circulating these tests as “proof” is highly problematic, and I suspect that very shortly they will circle the wagons.

 

Read More